The enigma of metformin-associated lactic acidosis

Clinical Toxicology

Volumn 52, Issue 2, 2014, Pages 85-87

  Juurlink, D N ^a   Roberts, D M ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; METFORMIN;

CAUSAL ATTRIBUTION; CLINICAL FEATURE; DRUG WITHDRAWAL; HUMAN; INCIDENCE; LACTIC ACIDOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; RISK FACTOR;

ACIDOSIS, LACTIC; FEMALE; HUMANS; MALE; METFORMIN;

EID: 84893437463     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2014.880174     Document Type: Note

References (13)

1. UK Prospective Diabetes Study . Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group . Lancet 1998; 352 : 854-865
2. Kajbaf F, Lalau JD . The prognostic value of blood pH and lactate and metformin concentrations in severe metformin-Associated lactic acidosis . BMC Pharmacol Toxicol 2013; 14 : 22
3. Seidowsky A, Nseir S, Houdret N, Fourrier F . Metformin-Associated lactic acidosis: A prognostic and therapeutic study . Crit Care Med 2009 ; 37 : 2191-2196
4. Owen MR, Doran E, Halestrap AP . Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain . Biochem J 2000 ; 348 : 607-614
5. El-Mir MY, Nogueira V, Fontaine E, Averet N, Rigoulet M, Leverve X . Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I . J Biol Chem 2000 ; 275 : 223-228
6. Duong JK, Furlong TJ, Roberts DM, Graham GG, Greenfi eld JR, Williams KM, Day RO . The role of metformin in metforminassociated lactic acidosis (MALA): Case series and formulation of a model of pathogenesis . Drug Saf 2013 ; April 3 (Epub ahead of print .doi:10.1007/s40264-013-0038-6
7. Lalau JD, Lacroix C . Measurement of metformin concentration in erythrocytes: Clinical implications . Diabetes Obes Metab 2003 ; 5 : 93-98
8. Misbin RI, Green L, Stadel BV, Gueriguian JL, Gubbi A, Fleming GA . Lactic acidosis in patients with diabetes treated with metformin . N Engl J Med 1998 ; 338 : 265-266
9. Stang M, Wysowski DK, Butler-Jones D . Incidence of lactic acidosis in metformin users . Diabetes Care 1999 ; 22 : 925-927
10. Stacpoole PW, Wright EC, Baumgartner TG, Bersin RM, Buchalter S, Curry SH, et al . A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults . The dichloroacetate-lactic acidosis study group. N Engl J Med 1992 ; 327 : 1564-1569
11. Vecchio S, Giampreti A, Petrolini VM, Lonati D, Protti A, Papa P, et al . Metformin accumulation: Lactic acidosis and high plasmatic metformin levls in a retrospective case series of 66 patients on chronic therapy . Clin Toxicol 2014 ; 52 : 129-135
12. Barrueto F, Meggs WJ, Barchman MJ . Clearance of metformin by hemofi ltration in overdose . J Toxicol Clin Toxicol 2002 ; 40 : 177-180
13. Guo PY, Storsley LJ, Finkle SN . Severe lactic acidosis treated with prolonged hemodialysis: Recovery after massive overdoses of metformin . Semin Dial 2006 ; 19 : 80-83